Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

At one point, BMS said the facility would house 400 people. That was before Chairman and CEO Chris Boerner replaced Giovanni ...

Continued progress with lead program, CX-2051 (EpCAM PROBODY® Topo-1 ADC), in Phase 1a study in advanced colorectal cancer with initial Phase ...

Bristol Myers Squibb (BMY) closed the most recent trading day at $60.18, moving +0.6% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 1.78%.

Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Novo Nordisk (NVO – Research Report) and Veeva Systems (VEEV ...

DelveInsight's "TEPMETKO Market Size, Forecast, and Market Insight Report" highlights the details around TEPMETKO, a kinase ...

In the device segment of the interventional neuroradiology market, the flow diversion stents category had a significant revenue share in 2024, driven by their versatile applications, clinical ...

An in-depth analysis of 50+ companies and 65+ pipeline drugs shaping the Molecular Glue market. The report covers therapeutics assessment by product type, development stage, route of administration, ...

With increasing biomarker-driven cancer treatments, TEPMETKO benefits from growing adoption in precision oncology. Competition from other MET inhibitors like TABRECTA (capmatinib) exists, but ...

The increasing prevalence of neurological disorders, such as cerebral aneurysms, ischemic strokes, and arteriovenous malformations (AVMs), is the key factor fueling the demand for interventional ...

ReviveMed's AI platform analyzes metabolite data, revealing insights into diseases and streamlining drug development for ...